BCL2 is a downstream effector of MIZ-1 essential for blocking c-MYC-induced apoptosis

Jagruti H Patel1, Steven B McMahon

  • 1Biomedical Graduate Studies, University of Pennsylvania, Philadelphia, Pennsylvania 19104, USA.

Insights

The c-MYC oncoprotein can trigger cell death by inhibiting the transcription factor MIZ-1, which normally promotes survival by activating BCL2. Targeting this MIZ-1/BCL2 pathway reactivates c-MYC

Area of Science:

  • Molecular oncology
  • Cell death pathways
  • Cancer biology

Background:

  • The c-MYC oncoprotein drives cell transformation but can also induce apoptosis.
  • Understanding c-MYC's distinct pathway activation in apoptosis versus transformation is key for cancer therapy.
  • Previous work showed c-MYC-induced apoptosis requires MIZ-1 inactivation.

Purpose of the Study:

  • To identify the pro-survival gene regulated by MIZ-1.
  • To elucidate the role of the MIZ-1/BCL2 pathway in c-MYC-mediated apoptosis.
  • To explore therapeutic strategies targeting this pathway.

Main Methods:

  • Investigated the interaction between c-MYC and MIZ-1.
  • Analyzed gene expression changes, specifically BCL2 transcription.
  • Utilized short hairpin RNA (shRNA) and small molecule inhibitors against BCL2.
  • Assessed the apoptotic potential of a MIZ-1-defective c-MYC mutant.

Main Results:

  • MIZ-1 directly activates the transcription of the pro-survival gene BCL2.
  • Inhibition of the MIZ-1/BCL2 signaling axis is essential for c-MYC-induced apoptosis.
  • Targeting BCL2 with shRNA or inhibitors restored apoptosis in cells with a MIZ-1-inhibitory defective c-MYC mutant.

Conclusions:

  • Repression of BCL2 transcription is a critical outcome of MIZ-1 pathway targeting during c-MYC-induced apoptosis.
  • This defines a genetic pathway linking c-MYC, MIZ-1, and BCL2 in apoptosis.
  • These findings explain the cooperation between c-MYC and BCL2 in cancer development.

Related Concept Videos

The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
M-Cdk Drives Transition Into Mitosis02:15

M-Cdk Drives Transition Into Mitosis

Checkpoints throughout the cell cycle serve as safeguards and gatekeepers, allowing the cell cycle to progress in favorable conditions and slow or halt it in problematic ones. This regulation is known as the cell cycle control system.
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
M-Cdk Drives Transition Into Mitosis02:15

M-Cdk Drives Transition Into Mitosis

Checkpoints throughout the cell cycle serve as safeguards and gatekeepers, allowing the cell cycle to progress in favorable conditions and slow or halt it in problematic ones. This regulation is known as the cell cycle control system.
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...